Continued progress toward planned development for SENS-401 and gene therapy programs Positive progress for two clinical trials for SENS-401: in Cisplatin-Induced Ototoxicity (CIO) and to prevent residual hearing loss following cochlear implantation Development milestone achieved for the OTOF-GT program with delivery of batches for the toxicology study; plan to file Clinical Trial Application in 1H … [Read more…]
HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its Chief Executive Officer, Dr. Sherif Abdou, will participate on the “Next Frontier – Value Based Care for Sub-Capitation/Specialties” virtual panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22nd at 9:00 am … [Read more…]
Initial safety run‐in results from LOTIS-5 Phase 3 trial demonstrate ORR of 75% and 40% CR rate with no new safety signals Cami pivotal Phase 2 data to be highlighted in encore oral and poster presentations LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today announced that ZYNLONTA® (loncastuximab tesirine-lpyl) and camidanlumab tesirine (Cami) abstracts have … [Read more…]
– Piyush Sharma to Serve as Chief Ethics and Compliance Officer and Evan Lippman as Chief Corporate Development and Strategy Officer – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the appointment of two new members to the management team – Piyush Sharma as Chief Ethics & Compliance Officer … [Read more…]
Healthsharing ministry shares helpful practices for developing gratitude to overcome the negative effects of the pandemic on mental health NORFOLK, Va.–(BUSINESS WIRE)–Unite Health Share Ministries™ (UHSM), a nonprofit, faith-based healthcare sharing ministry supporting Christian believers through member-to-member healthcare sharing memberships, celebrates World Gratitude Day Wednesday, September 21st, by sharing the benefits of practicing gratitude and … [Read more…]
NASHVILLE, Tenn.–(BUSINESS WIRE)–#SustainableHealthcare—On September 14, 2022, Health Evolution Connect, an invitation-only event, kicked off with a networking event hosted by Enlace Health, a healthcare transformation company that powers the systematic changes needed for sustainable healthcare. Participants included CEO and C-Suite executives from providers, payers, and life science organizations, along with technology leaders, investors, innovators, and … [Read more…]
LARKSPUR, Calif.–(BUSINESS WIRE)–#GBMAGILE–Global Coalition for Adaptive Research (GCAR), Sponsor of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) master protocol, announced that regorafenib has completed enrollment and follow-up in GBM AGILE. Enrollment for the arm was stopped after an interim analysis showed a low probability of sufficient improvement in overall survival as compared with randomized … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)” training has been added to ResearchAndMarkets.com’s offering. In this two-day workshop conference, you will learn the requirements and expectations of major healthcare regulators that are applicable to “virtual” companies. Today, many companies operate on an outsourcing model. This is very common for … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Cancer Stem Cell Market By Cancer Type, By Transplant, By End-use, and By Region Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Stem Cells Market size is estimated to reach USD 2.98 Billion from USD 1.14 Billion in 2021, delivering a growth rate of 11% through 2030, according … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredients Market Analysis by Type of Synthesis, by Type of Manufacturers, by Type, by Application, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global active pharmaceutical ingredients market size is estimated to be USD 199.8 billion in 2020 and is expected to witness … [Read more…]
